| Product NDC: | 68180-202 |
| Proprietary Name: | SUPRAX |
| Non Proprietary Name: | CEFIXIME |
| Active Ingredient(s): | 100 mg/5mL & nbsp; CEFIXIME |
| Administration Route(s): | ORAL |
| Dosage Form(s): | POWDER, FOR SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68180-202 |
| Labeler Name: | Lupin Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065129 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20040301 |
| Package NDC: | 68180-202-01 |
| Package Description: | 100 mL in 1 BOTTLE (68180-202-01) |
| NDC Code | 68180-202-01 |
| Proprietary Name | SUPRAX |
| Package Description | 100 mL in 1 BOTTLE (68180-202-01) |
| Product NDC | 68180-202 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | CEFIXIME |
| Dosage Form Name | POWDER, FOR SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 20040301 |
| Marketing Category Name | ANDA |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | CEFIXIME |
| Strength Number | 100 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient] |